Olema board member resigns, replacement named to two committees
Dr. Gorjan Hrustanovic stepped down from Olema Pharmaceuticals' board effective October 14, 2026, and Dr. Prakash Raman took over his committee seats.
Olema Pharmaceuticals disclosed in an 8-K filing that Dr. Gorjan Hrustanovic notified the company on October 12, 2026 of his decision to resign from its Board of Directors, effective October 14, 2026.1 He also stepped down from the Board's Compensation Committee and its Science and Technology Committee.1
The filing states that the resignation did not stem from any disagreement with the company over its operations, policies, or practices.1 Olema said it thanks Dr. Hrustanovic for his service and contributions to the company and the board.1
Three days later, Olema filled the vacated committee seats. On October 15, 2026, the board, acting on a recommendation from its Nominating and Corporate Governance Committee, named Dr. Prakash Raman to both the Compensation Committee and the Science and Technology Committee, effective that same day.1
The 8-K was signed on behalf of Olema by Sean Bohen, M.D., Ph.D., the company's President and Chief Executive Officer, dated October 15, 2026. The filing did not disclose any additional details regarding Dr. Raman's background or further changes to the board's composition.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.